Rhythm Pharmaceuticals ( RYTM +2.09%) is another biotech stock (in this case, a mid-cap stock) that I think could easily ...

A stock increasing nearly 300% in a single year is remarkable. Bloom Energy 's ( BE +0.39%) stock has exploded and the ...

Despite its fourth-quarter results being pretty solid, the share price of pharmaceutical giant AbbVie ( ABBV +1.71%) fell ...

Silver surged by a whopping 144% during 2025, partly because investors piled into precious metals to hedge against rising ...

Coca-Cola ( KO 0.43%), like Target, is also a Dividend King, meaning you likely can count on this company for passive income over the long term. And the beverage giant's massive level of free cash ...

The energy company tumbled over the past month as regulators discussed emergency auctions and capacity-market price collars in one of its key markets.

That's one of the reasons why there's still time to invest in the Invesco QQQ Trust. This trend of rising passive fund flows ...

Duolingo's daily and monthly user metrics reached a new inflection point in 2025. The platform broke past 50 million daily ...

Its stock is down, making its price more attractive.

Many analysts expect Kevin Warsh, who could become the next Fed chair this May, to continue cutting rates to spur fresh ...

These companies should benefit from a normalization of the healthcare market in 2026, making them cheap buys today.

With the support of the "Takaichi Trade," Japanese stocks and this iShares ETF could extend their hot starts to 2026.